Daniel Amann
CEO
SOFY GmbH (edupression)
Klosterneuburg, Austria
7 profile visitsSpeakerPanel Speaker
My organisation
SOFY GmbH develops and manufactures regulated digital medical devices (DiGA). edupression® is a digital therapeutic for the treatment of unipolar depression and holds permanent approval within the German DiGA system. It is prescribed by licensed physicians and psychotherapists and reimbursed as part of standard healthcare provision.
About me
Additional questions
International markets (regions) of interest
Oceania (e.g. Australia, New Zealand) East Asia (e.g. China, Japan)South East Asia (e.g. Thailand, Philippines)South Asia (e.g. India)Arabia & Middle East (e.g. Emirates)Africa Subsahara (e.g. Nigeria, South Africa)North AfricaLatin and South America (e.g. Mexico, Chile)North America (USA & Canada)Scandinavia (Nordics)Baltic StatesCentral and Western EuropeSouth and East Europe
Speaker sessions (1)
Tuesday, 24 March 2026
13:30 - 14:30
Internationalisation in the digital health sector
Location:Julius Raab Saal Track:Panel discussion
- Mental Health
- Digitalisation
- Internationalisation
- Health care
From telemedicine to mental health